Aurora Innovation, Inc. Quarterly report pursuant to Section 13 or 15(d)

Equity Incentive Plans (Tables)

6 Months Ended

Jun. 30, 2023

Total stock-based compensation expense by function was as follows (in millions):


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Research and development	$	37	$	42	$	71	$	68
Selling, general, and administrative	6		5		11		8
Total	$	43	$	47	$	82	$	76

RSU activity under the Plan and the 2017 Plan was as follows (in millions, except per share amounts):


	Number of shares	Weighted- average grant date fair value
Unvested at December 31, 2022	103	$	3.70
Granted	48	1.43
Vested	(19)	3.74
Forfeited	(9)	3.29
Unvested at June 30, 2023	123	$	2.85

Stock options granted under the Plan and the 2017 Plan during the six months ended June 30, 2023 were as follows:


	Six Months Ended June 30, 2023

Stock options granted (in millions)	46
Weighted average grant date fair value	$	0.79
Weighted average grant date fair value assumptions:
Expected term	5.8 years
Risk-free interest rates	4.3		%

Expected volatility	55.0		%

Stock option activity under the Plan and the 2017 Plan was as follows (in millions, except per share amounts):


	Number of shares	Weighted average exercise price		Weighted average remaining contractual term (in years)	Aggregate intrinsic value
Outstanding at December 31, 2022	63	$	1.76
Granted	46	1.44
Exercised	(3)	0.58
Forfeited	(3)	2.29
Expired	(2)	2.79
Outstanding at June 30, 2023	101	$	1.62	7.8	$	127
Exercisable at June 30, 2023	46	$	1.47	6.0	$	67